Blueprint Medicines (BPMC) News Today $128.27 +0.07 (+0.05%) Closing price 07/3/2025 02:27 PM EasternExtended Trading$128.27 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BPMC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Moody Aldrich Partners LLC Takes $1.98 Million Position in Blueprint Medicines Corporation (NASDAQ:BPMC)July 4 at 6:43 AM | marketbeat.comBlueprint Medicines Corporation (NASDAQ:BPMC) Receives $128.06 Consensus Target Price from AnalystsJuly 2 at 3:07 AM | americanbankingnews.comBlueprint Medicines (NASDAQ:BPMC) Hits New 52-Week High - Still a Buy?July 1, 2025 | marketbeat.comBPMC Blueprint Medicines Corporation - Seeking AlphaJuly 1, 2025 | seekingalpha.comPeregrine Capital Management LLC Sells 2,663 Shares of Blueprint Medicines Corporation (NASDAQ:BPMC)June 30, 2025 | marketbeat.comBlueprint Medicines Corporation (BPMC) - Yahoo FinanceJune 29, 2025 | finance.yahoo.comDiversified Trust Co Grows Position in Blueprint Medicines Corporation (NASDAQ:BPMC)June 29, 2025 | marketbeat.comBlueprint Medicines Corporation (NASDAQ:BPMC) Receives Average Recommendation of "Hold" from AnalystsJune 29, 2025 | marketbeat.comAMI Asset Management Corp Invests $970,000 in Blueprint Medicines Corporation (NASDAQ:BPMC)June 26, 2025 | marketbeat.comBlueprint Medicines Presents Strong Long-Term Data for AYVAKIT in Systemic MastocytosisJune 24, 2025 | msn.comBlueprint Medicines (NASDAQ:BPMC) Sees Strong Trading Volume - Here's What HappenedJune 24, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Hits New 1-Year High - Here's WhyJune 23, 2025 | marketbeat.comBLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint ...June 22, 2025 | morningstar.comMSG Americas Securities LLC Has $644,000 Position in Blueprint Medicines Corporation (NASDAQ:BPMC)June 22, 2025 | marketbeat.comBLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMCJune 20, 2025 | businesswire.comBlueprint Medicines (NASDAQ:BPMC) Earns Equal Weight Rating from Wells Fargo & CompanyJune 17, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Sees Large Volume Increase - Should You Buy?June 16, 2025 | marketbeat.comHAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Blueprint Medicines Corporation (NASDAQ: BPMC)June 15, 2025 | globenewswire.comAssenagon Asset Management S.A. Reduces Position in Blueprint Medicines Co. (NASDAQ:BPMC)June 15, 2025 | marketbeat.comGAMMA Investing LLC Purchases 28,615 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)June 13, 2025 | marketbeat.comBlueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI CongressesJune 12, 2025 | prnewswire.comBlueprint Medicines (NASDAQ:BPMC) Reaches New 12-Month High - Should You Buy?June 11, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Stake Raised by Rhumbline AdvisersJune 11, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Sees Strong Trading Volume - Here's WhyJune 10, 2025 | marketbeat.comBest Growth Stocks To Follow Now - June 9thJune 9, 2025 | marketbeat.comUBS Sticks to Its Hold Rating for Blueprint Medicines (BPMC)June 8, 2025 | theglobeandmail.comNBC Securities Inc. Purchases 2,646 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)June 8, 2025 | marketbeat.comGrowth Stocks To Follow Now - June 5thJune 5, 2025 | marketbeat.comMorgan Stanley Issues Positive Forecast for Blueprint Medicines (NASDAQ:BPMC) Stock PriceJune 5, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Given New $129.00 Price Target at UBS GroupJune 5, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Stock Rating Lowered by GuggenheimJune 5, 2025 | marketbeat.comCiti Sticks to Its Sell Rating for Blueprint Medicines (BPMC)June 4, 2025 | theglobeandmail.comCitigroup Upgrades Blueprint Medicines (BPMC)June 4, 2025 | msn.comPromising Mid Cap Stocks To Follow Now - June 3rdJune 4, 2025 | marketbeat.comTop Pharmaceutical Stocks To Watch Now - June 3rdJune 4, 2025 | marketbeat.comPromising Growth Stocks To Follow Now - June 3rdJune 4, 2025 | marketbeat.comTop Growth Stocks To Follow Now - June 4thJune 4, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Sees Large Volume Increase - What's Next?June 4, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Upgraded by Citigroup to "Neutral" RatingJune 4, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Cut to "Hold" at TD CowenJune 4, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Stock Rating Lowered by Citizens JmpJune 4, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Given Consensus Recommendation of "Hold" by AnalystsJune 4, 2025 | marketbeat.comPromising Value Stocks To Follow Today - June 2ndJune 3, 2025 | marketbeat.comMid Cap Stocks To Keep An Eye On - June 2ndJune 3, 2025 | marketbeat.comPharmaceutical Stocks To Consider - June 2ndJune 3, 2025 | marketbeat.comTop Medical Stocks To Research - June 2ndJune 3, 2025 | marketbeat.comPromising Growth Stocks To Follow Today - June 2ndJune 3, 2025 | marketbeat.comBlueprint Medicines' (BPMC) Sector Perform Rating Reiterated at ScotiabankJune 3, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Earns "Neutral" Rating from JPMorgan Chase & Co.June 3, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Shares Gap Up - Still a Buy?June 3, 2025 | marketbeat.com Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address BPMC Media Mentions By Week BPMC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼0.810.58▲Average Medical News Sentiment BPMC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼89▲BPMC Articles Average Week Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ONC News Today BNTX News Today TEVA News Today INSM News Today SMMT News Today ITCI News Today GMAB News Today RDY News Today QGEN News Today MRNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Blueprint Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.